Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers on track to meet fiscal year 2024 targets after second quarter
Press release

Siemens Healthineers on track to meet fiscal year 2024 targets after second quarter

Siemens Healthineers AG today announces its results for the second quarter of fiscal year 2024 ended March 31, 2024.

Published on 7. Mai 2024
<p><strong>Q2 Fiscal Year 2024&nbsp;</strong></p><ul><li>Good equipment book-to-bill ratio of 1.08&nbsp;</li><li>Comparable revenue growth of 3.0% against a very good prior-year quarter (excluding rapid COVID-19 antigen tests, growth of 11.2%)&nbsp;</li><li>Imaging comparable revenue growth of 2.6% against significant growth in the prior-year quarter; adjusted EBIT margin of 20.2%&nbsp;</li><li>Diagnostics comparable revenue growth of 3.7% (excluding rapid COVID-19 antigen tests 4.1%); adjusted EBIT margin 4.1%, clearly above the prior-year quarter&nbsp;</li><li>Varian comparable revenue down slightly by 2.1% against the excellent prior-year quarter (growth of 27%); clear improvement in adjusted EBIT margin to 16.4%&nbsp;</li><li>Advanced Therapies comparable revenue growth of 8.0% against very strong growth in the prior-year quarter; adjusted EBIT margin of 16.2%&nbsp;</li><li>Overall adjusted EBIT margin of 15.1%&nbsp;</li><li>Adjusted basic earnings per share of €0.55</li></ul><p><strong>Outlook for Fiscal Year 2024&nbsp;</strong></p><p>We confirm our expectation of comparable revenue growth of between 4.5% and 6.5% (between 5.0% and 7.0% excluding revenue from rapid COVID-19 antigen tests) and adjusted basic earnings per share of between €2.10 and €2.30.&nbsp;</p><p><strong>Bernd Montag, CEO of Siemens Healthineers AG:&nbsp;</strong></p><p><em>»The Healthineers team has continued its successful growth trajectory, even relative to an excellent prior-year quarter. After an overall strong first half of the year, we are once again well on our way to achieving our targets for the financial year.«</em></p>

Download Quarterly Statement(pdf, 283.90 KB)

Siemens Healthineers 2024

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.